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Available online 8 May 2012The sera of a retrospective cohort (n=41) composed of children with well characterized cow's
milk allergy collected from multiple visits were analyzed using a protein microarray system
measuring four classes of immunoglobulins. The frequency of the visits, age and gender
distribution reflected real situation faced by the clinicians at a pediatric reference center for
food allergy in São Paulo, Brazil. The profiling array results have shown that total IgG and IgA
share similar specificity whilst IgM and in particular IgE are distantly related. The correlation of
specificity of IgE and IgA is variable amongst the patients and this relationship cannot be used
to predict atopy or the onset of tolerance to milk. The array profiling technique has
corroborated the clinical selection criteria for this cohort albeit it clearly suggested that 4 out of
the 41 patients might have allergies other than milk origin. There was also a good correlation
between the array data and ImmunoCAP results, casein in particular. By using qualitative and
quantitative multivariate analysis routines it was possible to produce validated statistical
models to predict with reasonable accuracy the onset of tolerance to milk proteins. If expanded
to larger study groups, the array profiling in combination with the multivariate techniques
show potential to improve the prognostic of milk allergic patients.
© 2012 Elsevier B.V. Open access under CC BY license. Keywords:
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Tolerance1. Introduction
Cow's milk is one of the most common trigger foods
causing food allergy in the first years of life. It affects around
2.5% of young children with severe consequences for the
quality of life of both patient and family (Skripak et al., 2007).
Cow's milk is composed of several allergenic proteins includ-
ing casein, β-lactoglobulin and α-lactalbumin (Wal, 1998).'s milk protein; HRP,
oCAP(CAP), IgE deter-
e-linked immunosor-
x: +44 115 9516122.
(MJC. Alcocer).
Y license. Symptoms of CMA range from mild to anaphylactic re-
actions and depend on immune mechanisms, being the one
associated with Immunoglobulin E (IgE) the most common.
The current treatment consists of a restricted diet with
complete avoidance of triggering food.
The majority of patients outgrow their CMA at around
three years of age (Host and Halken, 1990). In the last decade
this picture has changed, with an increasing number of
patients remaining allergic to cow's milk for a longer period
(Host, 2002; Skripak et al., 2007).
In general, the kinetics and the immunoglobulin isotypes
associated with the acquisition of tolerance are not well
described. Hence in order to minimize testing and potential
hazards of re-introducing CMP too early, a method for
prediction of tolerance other than challenge testing would
be helpful. Various authors have studied the predictive value
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are few studies (Roehr et al., 2001; Garcia-Ara et al., 2004;
Vanto et al., 2004; Martorell et al., 2006, 2008). The pre-
dictive diagnostic values needed to be dynamically adjusted
over the course of follow up as the patients become older and
must consider the association with other atopic disease,
mainly atopic dermatitis (Garcia-Ara et al., 2004; Martorell
et al., 2008). Fewer studies have addressed the immuno-
globulin isotype changes underlying the establishment of
milk tolerance (Sicherer and Sampson, 1999).
With the recent advances in microarray and computation
technology, several different platforms are now available for
the profiling of the IgE, including specific milk protein
fractions (Hochwallner et al., 2010). Although most of the
commercial microarrays can be very sensitive and specific,
they are still restricted in the broad representation of the
sensitizing material and lack the comparative information of
the other abundant immunoglobulins (Renault et al., 2011).
Regardless of the system used, the major obstacle for the
interpretation of microarray profiling data is the almost
intractable complexity of data generated. In this work, we
borrowed a collection of multivariate statistical routines
widely used by engineers and scientists in chemometrics-
based research to explore multivariate data and build
predictive models. The statistical routines employed use
correlation structures present amongst thousands of micro-
array spots to reduce those into linear combinations
representing a limited number of systematic trends. A sample
can then be characterized by the ‘weight’ of each of the
trends present within the different samples under consider-
ation, simplifying greatly their graphical representation or
the prediction of an external variable.
By using a particular retrospective cohort of clinically well
characterized CMA children of various age and samples
collected from those patients in multiple visits, we aimed atTable 1
Main protein extracts printed on the 16 pad array. The extraction, printing and pro
2011). The individual extracts were printed in triplicate protein spots. Antibody co
Vegetables Fruits
Carrot, Celery, Peas, Pepper (red). Apple, Banana, Coconut, Kiwi,
Beans Nuts
Broad bean, Chickpea, Haricot Bean, Lentil,
Soybean, Soybean milk and fractions.
Almond, Brazil Nut, Cashew, H
Pine Kernel, Pistachio, Walnut
Seeds Dairy
Sesame, Sunflower. Edam, Mozzarella, Parmesan,
Milk (cow) and milk fractions
Fish Others
Cod, Craw, Salmon, Smoked Haddock Chocolate, Beer.
Shellfish Eggs
Crab, Lobster, Mussels, Prawn Duck (yolk), Duck (white), He
Hen (yolk), Ovalbumin (Hen)
Dog Cat
Dog dander, Dog hair Cat dander, Cat hair,reporting a real situation faced by pediatric allergist at
Brazilian reference center for food allergy and possibly
worldwide. This cohort, although reduced, when analyzed
by a large and comprehensive array with four immunoglob-
ulin isotypes, resulted into qualitative and quantitative
information that were modeled into predictive routines.
2. Method and study population
2.1. Microarray analysis
The protein microarray analyses (extract preparations,
printing, and hybridization) for the four immunoglobulin
isotypes (IgA, IgG, IgM and IgE) using a four-laser scanner
were carried out essentially as previously described (Renault
et al., 2011) but using 16-pad nitrocellulose coated glass
slides (FAST slides; Whatman Schleicher & Schuell; Dassel,
Germany) instead of the full pad described therein. The list
of extracts used in this reduced set is shown in Table 1. Data
from the scanner was processed using GenePix Pro software
v6.0.1.27 (Axon Instruments). Triplicate spot readings were
averaged for both the serum sample slide and the control
slide (no serum sample).
2.2. Data analysis
Control protein spot microarray data was subtracted
from the sample slide to eliminate non-specific binding and
inherent autofluorescence of some proteins using dedicated
in-house programs run on Matlab (version 7.1 (R14SP3),
The Mathworks Inc., USA) using an Excel link toolbox
(Mathworks) and the Dataset Object (Version 5.0, Eigen-
vector Research Inc., USA). Univariate Statistics were
performed using SPSS (PASW Statistics 18, IBM, USA).
Multivariate Data Analysis was carried out using the PLScessing were carried out essentially as previously described (Renault et al.,
ntrols and internal markers are not shown.
Herbs and Spices
Kiwi fractions, Pear. Basil, Fenugreek, Parsley, Vanilla.
Cereals
azelnut, Peanut,
.
Oats, Rye, Wheat.
Meat
Yogurt (Plain),
.
Beef, Chicken, Lamb, Pork (Ham), Turkey.
Enterobacteria
Citrobacter, E. coli, Campylobacter
Inhaled allergens
n (white),
.
Birch pollen extract, House dust mite extract,
Grass pollen extract, Bet v 1.
Fungi
Yeast (Sacharomyces cerevisae).
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using Principal Components Analysis (PCA) (Pearson, 1901)
for data exploration/visualization and Partial Least Squares
Regression (PLSR) (Geladi and Kowalski, 1986) method for
building regression models. PLS‐DA (Ståhle and Wold, 1987)
was used for general classification. Internal cross validation
was employed to assess the number of latent variables
(aforementioned data trends) necessary to build models that
were as concise as possible with minimal predictive error.
During cross validation, random subsets of the data were
left out and regression models with increasing complexity
(numbers of latent variables) were built with the remaining
data. The prediction error was then determined for each of the
left out sample subsets at each model complexity and an
average prediction/classification error per number of latent
variables was established. The result was an estimation of the
most appropriate number of latent variables (with lowest
error) as well as an estimation of the prediction/classification
error to be expected when applying the model to new data.2.3. Study population and serum samples
Amongst 168 children with CMA followed at the Brazilian
Food Allergy Reference Centre, a subset of 41 children was
selected representing patients with >3 sequential serum
samples taken during the follow-up. Of these selected
patients, 21 were tolerant patients. All children in this cohort
had at least one sample collected before the development of
tolerance. The IgE-mediated CMA diagnosis was carried out
based on the following criteria: personal or familial atopy,
clinical symptoms occurring until 2 h after the cow's milk
ingestion and specific IgE by ImmunoCAP (Pharmacia-
Uppsala) >0.35 KU/L and/or Prick test with wheal >3 mm
for whole cow's milk and its fractions showing sensitization.
Other food allergens were tested by ImmunoCAP because
multiple food allergy was associated with persistent CMA. All
non-anaphylactic children were submitted to double blind
placebo controlled food challenge (DBPCFC) to confirm the
CMA diagnosis as described by Gushken et al. (in press).
Anaphylactic children were diagnosed based on this clinical
manifestation associated to sensitization showed by Immu-
noCAP >0.35. The diagnosis of tolerance was done by the
absence of clinical reactivity during the food challenge tests.
Open challenge was indicated when there was the informa-
tion of exposure to milk without symptoms or during the
DBPCFC.
Among allergic and tolerant patients, the gender dis-
tribution was M:F=1.7:1 and the median age of onset of
symptoms was 120 days. The most common clinical mani-
festations were cutaneous findings and anaphylaxis. The
median of total serum IgE levels was 263 kU/L (ELISA). The
control group was composed of children referred to the
Allergy and Immunology Division in whom food allergy
diagnosis was excluded. An extended clinical description of
the patients included in this study is summarised in
Table 2.
The initial study about evolution of CMA patients received
approval from the Ethical Committee from the Pediatric
Department and CAPPesq (Hospital das Clinicas, FMUSP
Ethical committee). The Microarray testing system has beenapproved by the Local Ethical Medical Committee from the
University of Nottingham.
3. Results and discussion
3.1. Speciﬁcity correlations of Ig
The specific overall correlation amongst the immuno-
globulin isotypes was variable but with a discerning pattern.
The children within this cohort (Fig. 1) showed good average
correlation between specific IgA and IgG data (r>0.85) and
less well with IgM>>IgE (rb0.04). In agreement with our
previous study with adult patients (Renault et al., 2011), the
correlation values are highly patient-dependent (Fig. 1),
nevertheless, the same pattern of high correlation between
specific IgG and IgA does hold. In general the correlation
values between Ig classes were positive but few patients
did show negative correlation particularly when IgE was
involved. Overall, the specificity of response to IgE poorly
correlated with the other classes being less related to IgM
than the others. Within the isotypes the largest amplitude
in variation of correlations was observed between IgE and
IgA values (Fig. 1).
In order to test whether the overall correlations between
classes could be used as discriminator for classification, those
coefficients for atopic and non-atopic groups of patients were
compared and overall showed some differences (ANOVA,
p values ranging between=b0.001 and 0.13). Inspection of
box plots (not shown) as well as R2 and adjusted R2 values
(ranging from 0.023 to 0.24 and 0.018 to 0.18, respectively)
showed that although the correlations between the Ig-
classes were different, they could not be used in univariate
statistic models to predict atopy. As expected when using
all correlations in a multivariate approach, PLS-DA pro-
duced a reasonable predictive value for this classification
(79% sensitivity and 84% specificity for prediction of atopy
for left out cross-validation samples; 3 latent variables were
used). Moreover, the model vectors relevant to prediction
(i.e. regression and Variable Importance of Projection (VIP)
vectors) produced valuable qualitative information, sug-
gesting the expected involvement of IgE by indicating that
only IgE/IgA or IgE/IgG correlation coefficients possessed
some power of discrimination.
3.2. All dataset
In order to assess the feasibility of using the immuno-
globulin isotypes readout directly, instead of correlation
coefficients, to predict milk allergy tolerance, all readouts
were used to train a PLS-DA model to discriminate between
tolerant and non-tolerant subjects. The resulting model (1
latent variable, data normalized and mean centered) was
able to predict tolerance with a cross-validation sensitivity
and specificity of 57% and 77% respectively. Inspection of the
regression vector values (result not shown) indicates that
achieving tolerance is paired with a decrease in dairy sen-
sitivity. The spots that showed the largest variation (de-
creases and increases) were mainly IgE and the medium
contributors mainly IgA driven. Taken together and bearing
in mind the clinical criteria of inclusion of the patients in this
study, these results were expected; they corroborate a large
Table 2
Clinical description of the selected children's cohort. Patients selected had at least 3 sequential sera taken during follow-up sessions. GM=goat milk =Hen egg, PN=peanuts, SB=Soybean, F=Fish, SR=Shrimp,
CR=corn, *=average value, C=Oral positive food challenge (double blind placebo controlled), A=Anaphylaxis.
Patient
number
Milk
tolerance
Gender Current
age
(year)
Diagnosis
criteria
Skin
symptom
GI
symptom
Respiratory
symptom
Anaphylaxis Other
food
allergy
Total
IgE*
(UI/ml)
ImmunoCAP
Cow's*
Milk(kU/L)
I unoCAP
α actoglobulin*
( /L)
ImmunoCAP
β- lactoglobulin
*(kU/L)
ImmunoCAP
casein*
(kU/L)
Age of milk
tolerance
(year)
17 Y M 5.4 C Y Y N N N 138 10.26 0 5.24 8.59 4
12 Y F 5.5 C Y N N N N 14 b0.35 b 5 0.44 b0.35 2.7
9 Y M 5.7 A Y N N Y N 169 0.36 b 5 b0.35 b0.35 3.2
4 Y M 5.8 C Y N N N N 495 0.61 5 0.54 0.48 3.3
22 Y M 5.8 C Y N N N N 72 0.96 9 0.40 0.82 3.1
7 Y M 6.5 C Y N N N SB 250 6.86 4 1.97 3.60 5.4
33 Y M 6.9 C Y N N N N nd 5.66 5 0.37 0.45 3.5
36 Y F 7.0 A Y Y Y Y N 438 b0.35 b 5 b0.35 b0.35 3.4
41 Y M 7.9 A Y N Y Y N 65 1.11 b 5 0.48 0.72 3.2
30 Y M 8.8 C Y N N Y N 778 6.49 1 1.65 3.34 4.9
21 Y M 9.3 C Y N N Y N 338 1.47 b 5 0.37 b0.35 5
29 Y M 9.7 C Y N N N E 2665 0.43 9 b0.35 0.41 4
40 Y M 9.8 A Y Y Y Y E 4707 17.83 1 9 5.28 5.95 10
27 Y M 10.3 A Y N N Y N 1902 1.25 8 0.45 0.50 5.3
15 Y F 10.4 C Y N N N N 35500 18.7 1 6.77 21.0 7.6
25 Y F 10.5 C Y Y N Y N 283 0.65 9 b0.35 0.48 6.5
8 Y F 10.6 C Y Y Y Y N 225 16.20 2 5.22 11.92 4
13 Y M 12.6 C Y N N N N 426 15.25 4 0.62 9.53 11.6
3 Y F 12.9 A Y Y Y Y GM 258 4.11 5 0.78 4.22 7.0
6 Y M 18.5 C Y N N N E,F 8126 4.72 2 0.68 2.39 12.2
1 Y F 20.8 C Y N Y Y GM 2305 9.40 6 2.09 9.26 17.0
16 N F 05.5 C Y N N N E,CR 7080 5.87 5 0.71 8.51
24 N F 05.7 C N N N N N 189 0.91 3 1.05 0.86
28 N M 05.9 C Y Y N N N 36 8.31 5 1.24 10.29
37 N M 07.9 A Y N N Y N 62 10.38 2 4.03 8.79
19 N F 08.3 C Y N N N N 1369 33.90 1 5 4.14 35.55
39 N M 08.5 C Y N Y Y N 1482 44.63 1 3 1.52 50.17
14 N M 08.6 C Y Y Y Y N 321 5.14 6 1.21 6.32
34 N F 08.8 A Y N Y Y N 301 40.90 9 22.39 45.05
32 N M 09.7 C Y N N N N 194 3.48 1 1.05 1.48
38 N M 09.9 A Y N Y Y N 992 20.94 5 1.59 20.00
10 N F 11.5 C Y Y Y Y PN 1950 66.78 3 3 25.04 72.73
26 N M 11.6 A Y Y Y Y E 667 6.39 1 0 2.73 4.76
31 N F 12.1 A Y N Y Y N 172 11.60 7 1.67 12.20
2 N M 12.3 C Y N N Y N 417 4.00 3 1.70 1.13
20 N F 12.7 C Y Y N N E 745 12.39 b 5 2.77 13.77
35 N M 13.2 A Y N Y Y SB,E, PN,GM 2041 16.24 1 1.70 18.99
11 N M 13.7 C Y Y Y Y N 462 30.53 1 1 11.12 36.57
5 N M 14.5 C Y N N N SR 1490 7.51 7 0.51 2.54
18 N F 14.5 A Y Y Y Y PN 301 8.97 3 0.87 2.62
23 N M 15.3 C N N N N N 49 42.26 0 58.1 29.47
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Fig. 1. Coefficient of correlation between immunoglobulin isotypes. The values for minimum, first quartile, median, third quartile, and maximum for each
individual patient and their immunoglobin isotype pair are summarized. If values are considered extreme the whiskers are set to maximum length of twice the
box, and the individual extreme values represented as a disc (or as a start if more than 3 box-lengths away from median).
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parameter to be followed.
3.3. Array speciﬁc IgE data
In agreement with the clinical selection criteria used and as
shown in Fig. 2 most of the children involved in this study have
shown high levels of specific IgE tomilk. Further, when clinically
diagnosedmilk allergic children were divided into “susceptible”
and the ones that have achieved milk “tolerance” after few
years, a statistically significant difference (ANOVA p=b0.001)
was observed between the groups with a much increased milk
specific IgE levels for the former (Fig. 2). Therefore the overall
contribution of IgE directed against food components other than
milk measured in this system was expected to be small.
In order to further characterize the type of interactions
observed within this IgE analysis, principal component analysis
(PCA) of the microarray data clustered by product was carried
out and is summarized in Fig. 3. Overall 84.4% of the variance
could be explained by the first 2 principal components. With
some interesting exceptions (patients #01, 02, 15 and 24)
PCA data corroborated the data shown in Fig. 2 and the
clinical diagnosis inclusion criteria with most of the patients
showing indeed a spatial distribution heavily biased towards
milk proteins (Fig. 3). The clustering of the different time
points for the same patients was also noticeable, showing
that even with the environmental challenges and time span
of many years between sampling, the specific IgE signature of
the individual patient is not as diverse as originally thought
and remained relatively constant.
Whilst consistent, the data shown in Fig. 3 have also shown
that four patients did not conform to the IgE milk dominatedsignature. Hence even within the relatively small number of
patients selected and presented here, if used as a prognostic
tool, the array profiling technique would have suggested that
milk might not have been the main or only target of the
treatment for all patients. As highlighted in Figs. 3 and 4, in
more extreme cases such as patient #02 “shellfish” alone and
not milk-specific IgE antibodies were the main sensitizing food
component. The high incidence of specific IgE to fish and eggs
in the Brazilian children population has been previously
reported (Naspitz et al., 2004) but unfortunately shellfish
allergens were not tested in this study. There is a remote
possibility that the high shellfish reaction might be due to
cross-reactivity of e.g. highly conserved tropomyosin with
ascarid nematodes, mites or cockroaches (Arruda and Santos,
2005). Patients such as #30 (Fig. 4) possessed low level of
specific antibodies to milk however, in this particular case,
coconut rather than cow's milk would have been the major
source of concern. This patient in particular possessed lowmilk
ImmunoCAP results and positive SPT with atopic dermatitis
symptoms when in contact with cow's milk.
Therefore whilst the absence of milk-specific IgE, as in the
non-atopic controls, is still an inclusion criterion for the milk
response group, higher specific IgE to other non-milk groups,
as seen in patients #2, 15, and 24 clearly should have ex-
cluded these patients from the milk alone group and
disturbed any mathematical modeling of the phenomenon.
3.4. Speciﬁc ImmunoCAP vs. Total IgE
Within this cohort total cow's milk ImmunoCAP results
correlate strongly with Casein (R2=0.918) and α-lactalbumin
ImmunoCAP (R2=0.708), while β-lactoglobulin ImmunoCAP
IgE results in groups
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Fig. 2. General profile of serum Immunoglobulin E obtained by the microarray measurements. Median data of fluorescent results (IgE) clustered in groups
(Table 1) with 10th, 25th, 75th and 90th percentiles are shown. Non-atopic patients are shown as “control” (Ctl). The milk allergic patients have been divided into
“tolerant” (Tol) after many visits or “sensitive” (Sens) if still positive reactants to milk.
Fig. 3. Principal component analysis of specific IgE measurements (array) clustered by groups of products. The Biplot shows the IgE by groups (Table 1) of
PC1×PC2 components overlaid by the variable “loadings” (in black dots) used in the separation. Different samples obtained from the same patients are clustered
together. Highlighted with red ellipses are the main patients that did not conform to the milk specific grouping (e.g.: patients # 02 and # 15 have mainly shellfish
related IgE response). Highlighted with a green ellipse are non-atopic control sera.
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Fig. 4. IgE profiling by patients and group of products. Each bar represents an average for the group and a single time point, with consecutive time-points grouped
together. Most of the patients located along the “dairy” direction shown in Fig. 4 possess the signature as shown for patient #20 (bottom profile). However some
others, for example patient #30 (coconut specific) do not conform to the milk signature as do the patients already highlighted in Fig. 4, (#02 and #15).
54 F. Wulfert et al. / Journal of Immunological Methods 382 (2012) 48–57are less but still significantly related to the main ImmunoCAP
casein values (R2=0.551) (Table 3). As shown in many
studies, total IgE values did not correlate with ImmunoCAP
results (Table 3) andwere also unable to discriminate between
children who acquired tolerance and children who were still
sensitive to milk up their last visit (p=0.305 ANOVA).
ImmunoCAP values for Cow's milk, Casein, β-lactoglobulin
(p=b0.001) but not α-lactalbumin (p=0.401) were able to
make this discrimination. Furthermore, within the cohort that
acquired milk tolerance during the time span of these visits,
there was a small but direct correlation of ImmunoCAP values
and age of tolerance i.e., higher casein or total cow's milk
ImmunoCAP values in children that acquired milk tolerance at
a later age (Table 3). These results are in agreement with the
larger specific average IgE values shown by the susceptible
group in the array data summary presented in Fig. 2.
3.5. Speciﬁc ImmunoCAP vs. IgE Array results
A cross-validated Partial Least Squares Regression (PLSR)
model was generated between the array data and theTable 3
Pearson's correlation values of IgE and ImmunoCAP results from sequential follow-
CAP Cow Milk CAP Alfa C
IgE UI/ml 0.106 (0.267) 0.0573 (0.556) 0
CAP Milk 0.708 (8E-026) 0
CAP Alpha L. 0
CAP Beta L.
CAP CaseinImmunoCAP results and shown in Fig. 5. The best PLSR fit
was achieved with Casein ImmunoCAP values (model fit
R2=0.7; cross validation R2=0.6) but regression was less
efficient for cow's milk (R2=0.57 and 0.45 for model and
cross validation respectively). Both models showed strongest
predictive contributions from dairy proteins as expected and
shown in Fig. 5B.
3.6. Prediction of tolerance originated from the
mathematical model
PLS-DA models that directly predicted onset of tolerance
based only on IgE array data did not result in accurate
models, only predicting 2/3 of the tolerant cases correctly.
Whether the rate of variation of the specific IgE content with
successive visits had a better predictive power was investi-
gated using the overall cumulative variation and the
variation of each patient per year (Fig. 6). Overall the
responses were very homogeneous with some exceptions.
One patient for instance has shown an increase in specific IgE
values with most of the groups tested. This contrasts withup sessions. Values represent R2; p values are within parenthesis.
AP Beta CAP Casein Tolerance age
.0427 (0.661) 0.102 (0.293) 0.317 (0.008)
.666 (68E-022) 0.918 (6.9E-066) 0.463 (0.000009)
.371(0.00001) 0.632 (2.4E-019) 0.236 (0.03)
0.551 (3.8E-014) 0.227 (0.03)
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Fig. 5. A: Comparison of ImmunoCAP and IgE microarray results. Cross validation predictions for PLSR using 3 latent variables predicting specific
ImmunoCAP casein from IgE array results. Different symbols/colors represent different patients, model fit R2=0.69; cross validation R2=0.61. B: Variable
importance for prediction for each of the proteins (clustered by product type for easier comparison), dairy proteins obviously had strongest influence on
ImmunoCAP Casein prediction.
55F. Wulfert et al. / Journal of Immunological Methods 382 (2012) 48–57another patient showing an increase in the specific IgE
response to dairy products only. Most of the remaining
patients showed a diminishing dairy IgE response with time
(Fig. 6). The slope of variation with time, variance and
covariance of the measurements were not significantly
predictive of any of the clinical parameters analyzed.
Conversely, corroborating the data described earlier be-
tween ImmunoCAP Casein and the age of onset of milk
tolerance (Table 3), the regression analysis of the specific IgE
array data employing partial least square method (PLS) was
also able to establish a relevant cross validated fit (R2=0.695)0 2 4 6 8 10
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Fig. 6. Variations of the IgE measurements after sequential follow-up sessions. Each
clustered by product group after successive visits. Negative slope indicates that thefor this variable (Fig. 7). These coefficients were obtained
when the products were clustered in groups as variables. A
higher cross-validation coefficient (R2=0.701) was obtained
using the individual measurement values instead of clustered
groups (not shown), however, the interpretation becomes
more cumbersome due to the amount of variables involved.
As shown in the insert in Fig. 7, the resulting VIP or quali-
tative peaks used for such group discrimination were not
only “dairy” products but to a lesser degree also “beans and
shellfish”. These were obviously particular deviation charac-
teristics of the limited cohort used here.12 14 16 18 20 22
roups
data point represents the “slope” of the specific IgE variation of each patient
levels of the IgE dropped over time.
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Fig. 7. Prediction of age of milk tolerance using the PLS model. PLS model for IgE grouped array results×Age of onset of tolerance, ‘Patients’ plotted with
diamonds, ‘Control’ group with squares. The VIP values for the IgE groups depicting the importance for the model, are depicted in the left top insert, R2 and model
information given in right bottom insert.
56 F. Wulfert et al. / Journal of Immunological Methods 382 (2012) 48–57The great advantage of producing a statistical model is to
be able to predict and test outcomes. Using the mathemat-
ical model produced by PLS (Fig. 7) the non-milk allergic
control patients for instance all have shown a period
b2 years to achieve tolerance, regardless of their actual
age. Likewise, the age of milk tolerance predicted for the
patients that had achieved milk tolerance is very close to
the actual measured age in the cross validation. Ideally, the
model should be validated and its prediction error quanti-
fied with an external new test set. Due to the difficulty of
acquiring suitable datasets and bearing in mind the intrinsic
limitations imposed by a retrospective study as the one
presented here, the process of cross validation (for one
iteration: leave at random 20% of samples out, predict with
the other 80%, repeat until each sample has been left out,
repeat for 17 iterations) was used both to estimate the
model complexity (7 latent variables) as well as to esti-
mate the error to be expected for new data. This is still far
from ideal but it sets the background for future studies
where larger numbers, frequent monitoring, planned and
controlled interventions would generate clearer and more
accurate mathematical trends.
4. Conclusions
The profiling array technique used in this work has shown
that IgG and IgA share the same specificity whilst IgM and in
particular IgE are distantly related. The correlation between
specificity of IgE and IgA is variable amongst the patients and
cannot be used to predict atopy or the onset of tolerance to
milk. The profiling technique has corroborated the clinical
selection criteria for this cohort albeit it clearly indicated that
4 out of the 41 patients might have allergies other than frommilk origin. There was also a good correlation between the
array data and ImmunoCAP results. By using multivariate
analysis and a particular retrospective cohort of clinically
well characterized CMA children collected from patients in
multiple visits, it was possible to produce statistical models
to predict the onset of the tolerance to milk. These results,
still in early stages of development, are encouraging and
reinforce the potential use of multivariate models for
prognostic analyses of complex profiling data.
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